KLF4, TGF-b1, and transplantation arteriosclerosis
KLF4、TGF-b1 与移植动脉硬化
基本信息
- 批准号:7820830
- 负责人:
- 金额:$ 3.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-06-01 至 2010-10-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesionsAffectAgeAnimalsAnti-Inflammatory AgentsAnti-inflammatoryArteriosclerosisAssesAtherosclerosisBase PairingBindingBinding SitesCause of DeathCell Differentiation processCell LineCellsCoronary arteryDNA BindingDevelopmentDiffuseDominant-Negative MutationEnzymesErythropoiesisFamilyFamily memberGelshift AnalysisGene ChipsGene ExpressionGenesGrowth FactorHeart TransplantationHumanImmune systemInfiltrationInflammatoryInterferon Type IILesionMacrophage ActivationMediatingMethodsMolecularPeptide HydrolasesPhasePlasminogen Activator Inhibitor 1PlayProcessProductionRNA InterferenceResearch PersonnelRoleScreening procedureSeriesSignal PathwaySignal TransductionSiteSmooth Muscle MyocytesStructureT-Cell ActivationTissue SampleTransforming Growth FactorsTransplantationZinc Fingersbasechemokinecytokinein vivoinsightinterestmacrophagemembernovel therapeuticsoverexpressionpreventprogramspromoterresearch studyresponsetranscription factorvascular inflammationyeast two hybrid system
项目摘要
Transplantation-associated arteriosclerosis (TAA) is the major cause of death in recipients who survive more
than one year after cardiac transplantation. TAA is characterized by infiltration of inflammatory cells followed
by the formation of a diffuse, concentric neointima in which smooth muscle cells and macrophages
accumulate. Cells of the immune system-particularly the macrophage-play a key role in TAA. Through
elaboration of inflammatory cytokines/ growth factors and release of proteolytic enzymes and chemokines,
activated macrophages are critical to TAA. As such, identification of factors that regulate macrophage
activation is of critical importance. Members of the Kruppel-like family of factors are transcription factors
which play important roles in regulating cell differentiation and activation. We identified a member of this
family termed KLF4 whose expression is highly expressed in macrophages associated with heart transplant
lesions in vivo. KLF4 expression correlates with the induction of activated macrophages in response to
interferon-gamma and is decreased in response to the anti-inflammatory growth factor, transforming growth
factor-betal (TGF-b1). KLF4 overexpression in macrophages potently induces markers of macrophage
activation such as iNOS and inhibits effects mediated by TGF-b1. These observations have led us to the
central hypothesis that KLF4 serves as a critical regulator of macrophage activation and TAA. In AIM1 of this
proposal we explore the mechanistic basis for KLF4's ability to inhibit TGF-b1 signaling. In AIM2, we
examine the ability of KLF4 to induce macrophage iNOS gene expression. Finally, in AIMS, we assess the
consequences of KLF4 overexpression on the development of TAA and on macrophage effector functions.
These studies will provide important insight regarding the role of KLF4 in regulating macrophage activation.
The results of these studies are of considerable scientific interest and may serve as the basis for novel
therapeutic strategies to modulate TAA and the macrophage response to cytokine stimulation.
移植相关动脉硬化(TAA)是受者死亡的主要原因,
心脏移植后一年。TAA的特征是炎性细胞浸润,
通过形成弥漫性、同心的新生内膜,其中平滑肌细胞和巨噬细胞
积累。免疫系统的细胞,特别是巨噬细胞,在TAA中起关键作用。通过
炎性细胞因子/生长因子的加工和蛋白水解酶和趋化因子的释放,
活化的巨噬细胞对TAA至关重要。因此,识别调节巨噬细胞的因素
激活是至关重要的。Kruppel样因子家族的成员是转录因子
其在调节细胞分化和活化中起重要作用。我们确认了一名
KLF 4家族,在心脏移植相关巨噬细胞中高度表达
体内病变。KLF 4表达与诱导活化的巨噬细胞应答
干扰素-γ,并减少响应抗炎生长因子,转化生长
因子β 1(TGF-β 1)。KLF 4在巨噬细胞中的过表达有效地诱导巨噬细胞标志物
激活如iNOS,并抑制TGF-β 1介导的作用。这些观察使我们得出
中心假设KLF 4作为巨噬细胞活化和TAA的关键调节剂。在AIM 1中
我们的建议是探索KLF 4抑制TGF-β 1信号传导的机制基础。在AIM 2中,我们
检测KLF 4诱导巨噬细胞iNOS基因表达的能力。最后,在AIMS中,我们评估
KLF 4过表达对TAA发展和巨噬细胞效应功能的影响。
这些研究将为KLF 4在调节巨噬细胞活化中的作用提供重要的见解。
这些研究的结果具有相当大的科学意义,可以作为新的基础。
调节TAA和巨噬细胞对细胞因子刺激的反应的治疗策略。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK W FEINBERG其他文献
MARK W FEINBERG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK W FEINBERG', 18)}}的其他基金
LncRNA SNHG12, vascular senescence, and atherosclerosis
LncRNA SNHG12、血管衰老和动脉粥样硬化
- 批准号:
10395512 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
LncRNA SNHG12, vascular senescence, and atherosclerosis
LncRNA SNHG12、血管衰老和动脉粥样硬化
- 批准号:
10163902 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
LncRNA MAARS, macrophage apoptosis, and atherosclerosis
LncRNA MAARS、巨噬细胞凋亡和动脉粥样硬化
- 批准号:
10626018 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
LncRNA MAARS, macrophage apoptosis, and atherosclerosis
LncRNA MAARS、巨噬细胞凋亡和动脉粥样硬化
- 批准号:
10413149 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
miR-615, AKT/eNOS signaling, and angiogenesis
miR-615、AKT/eNOS 信号传导和血管生成
- 批准号:
9973357 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
LncRNA SNHG12, vascular senescence, and atherosclerosis
LncRNA SNHG12、血管衰老和动脉粥样硬化
- 批准号:
9973625 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
LncRNA SNHG12, vascular senescence, and atherosclerosis
LncRNA SNHG12、血管衰老和动脉粥样硬化
- 批准号:
10606495 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
LncRNA MAARS, macrophage apoptosis, and atherosclerosis
LncRNA MAARS、巨噬细胞凋亡和动脉粥样硬化
- 批准号:
10031269 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
miR-615, AKT/eNOS signaling, and angiogenesis
miR-615、AKT/eNOS 信号传导和血管生成
- 批准号:
10159956 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
miR-615, AKT/eNOS signaling, and angiogenesis
miR-615、AKT/eNOS 信号传导和血管生成
- 批准号:
10400068 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
相似海外基金
Hormone therapy, age of menopause, previous parity, and APOE genotype affect cognition in aging humans.
激素治疗、绝经年龄、既往产次和 APOE 基因型会影响老年人的认知。
- 批准号:
495182 - 财政年份:2023
- 资助金额:
$ 3.74万 - 项目类别:
Investigating how alternative splicing processes affect cartilage biology from development to old age
研究选择性剪接过程如何影响从发育到老年的软骨生物学
- 批准号:
2601817 - 财政年份:2021
- 资助金额:
$ 3.74万 - 项目类别:
Studentship
RAPID: Coronavirus Risk Communication: How Age and Communication Format Affect Risk Perception and Behaviors
RAPID:冠状病毒风险沟通:年龄和沟通方式如何影响风险认知和行为
- 批准号:
2029039 - 财政年份:2020
- 资助金额:
$ 3.74万 - 项目类别:
Standard Grant
Neighborhood and Parent Variables Affect Low-Income Preschool Age Child Physical Activity
社区和家长变量影响低收入学龄前儿童的身体活动
- 批准号:
9888417 - 财政年份:2019
- 资助金额:
$ 3.74万 - 项目类别:
The affect of Age related hearing loss for cognitive function
年龄相关性听力损失对认知功能的影响
- 批准号:
17K11318 - 财政年份:2017
- 资助金额:
$ 3.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9320090 - 财政年份:2017
- 资助金额:
$ 3.74万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
10166936 - 财政年份:2017
- 资助金额:
$ 3.74万 - 项目类别:
Affect regulation and Beta Amyloid: Maturational Factors in Aging and Age-Related Pathology
影响调节和 β 淀粉样蛋白:衰老和年龄相关病理学中的成熟因素
- 批准号:
9761593 - 财政年份:2017
- 资助金额:
$ 3.74万 - 项目类别:
How age dependent molecular changes in T follicular helper cells affect their function
滤泡辅助 T 细胞的年龄依赖性分子变化如何影响其功能
- 批准号:
BB/M50306X/1 - 财政年份:2014
- 资助金额:
$ 3.74万 - 项目类别:
Training Grant
Inflamm-aging: What do we know about the effect of inflammation on HIV treatment and disease as we age, and how does this affect our search for a Cure?
炎症衰老:随着年龄的增长,我们对炎症对艾滋病毒治疗和疾病的影响了解多少?这对我们寻找治愈方法有何影响?
- 批准号:
288272 - 财政年份:2013
- 资助金额:
$ 3.74万 - 项目类别:
Miscellaneous Programs